Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Huebner

Showing results (121-130 of 201) with videos related to

Pageof 21
Sort By:
Leukemia|December 12, 2022
Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasmsCarla S Walti, Anna B Halpern, Hu Xie, et al.
Annals of Clinical Microbiology and Antimicrobials|October 13, 2022
Virulence, phenotype and genotype characteristics of invasive group B Streptococcus isolates obtained from Swedish pregnant women and neonatesEmily M Huebner, Margrét Johansson Gudjónsdóttir, Matthew B Dacanay, et al.
Plos Pathogens|February 15, 2020
B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infectionJames C Romero-Masters, Shane M Huebner, Makoto Ohashi, et al.
Leukemia|May 4, 2018
Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasmsAnna B Halpern, Megan Othus, Emily M Huebner, et al.
Haematologica|November 10, 2018
Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasmsAnna B Halpern, Megan Othus, Emily M Huebner, et al.
International Journal of Radiation Biology|March 15, 2021
Tumor aggressiveness is independent of radiation quality in murine hepatocellular carcinoma and mammary tumor modelsEshwar B Udho, Shane M Huebner, Dawn M Albrecht, et al.
Blood Advances|February 15, 2023
Invasive fungal infections after CLAG-M/CLAG chemotherapy for acute myeloid leukemia and high-grade myeloid neoplasmsJulian Lindsay, Carla S Walti, Anna B Halpern, et al.
American Journal of Obstetrics and Gynecology|May 23, 2020
Clinical characteristics of 46 pregnant women with a severe acute respiratory syndrome coronavirus 2 infection in Washington StateErica M Lokken, Christie L Walker, Shani Delaney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2020
Low Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Among Pregnant and Postpartum Patients With Universal Screening in Seattle, WashingtonSylvia M LaCourse, Alisa Kachikis, Michela Blain, et al.
American Journal of Obstetrics and Gynecology|January 30, 2021
Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington StateErica M Lokken, Emily M Huebner, G Gray Taylor, et al.
Pageof 21

Showing results (121-130 of 201) with videos related to

Sort By:
Pageof 21
Leukemia|December 12, 2022
Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasmsCarla S Walti, Anna B Halpern, Hu Xie, et al.
Annals of Clinical Microbiology and Antimicrobials|October 13, 2022
Virulence, phenotype and genotype characteristics of invasive group B Streptococcus isolates obtained from Swedish pregnant women and neonatesEmily M Huebner, Margrét Johansson Gudjónsdóttir, Matthew B Dacanay, et al.
Plos Pathogens|February 15, 2020
B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infectionJames C Romero-Masters, Shane M Huebner, Makoto Ohashi, et al.
Leukemia|May 4, 2018
Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasmsAnna B Halpern, Megan Othus, Emily M Huebner, et al.
Haematologica|November 10, 2018
Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasmsAnna B Halpern, Megan Othus, Emily M Huebner, et al.
International Journal of Radiation Biology|March 15, 2021
Tumor aggressiveness is independent of radiation quality in murine hepatocellular carcinoma and mammary tumor modelsEshwar B Udho, Shane M Huebner, Dawn M Albrecht, et al.
Blood Advances|February 15, 2023
Invasive fungal infections after CLAG-M/CLAG chemotherapy for acute myeloid leukemia and high-grade myeloid neoplasmsJulian Lindsay, Carla S Walti, Anna B Halpern, et al.
American Journal of Obstetrics and Gynecology|May 23, 2020
Clinical characteristics of 46 pregnant women with a severe acute respiratory syndrome coronavirus 2 infection in Washington StateErica M Lokken, Christie L Walker, Shani Delaney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2020
Low Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Among Pregnant and Postpartum Patients With Universal Screening in Seattle, WashingtonSylvia M LaCourse, Alisa Kachikis, Michela Blain, et al.
American Journal of Obstetrics and Gynecology|January 30, 2021
Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington StateErica M Lokken, Emily M Huebner, G Gray Taylor, et al.
Pageof 21